Conceptualizing patterns in the dynamics of emerging technologies: The case of biotechnology developments in the Netherlands

Technovation

Volumn 29, Issue 4, 2009, Pages 247-264

  van der Valk, Tessa ^a   Moors, Ellen H M ^a   Meeus, Marius T H ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Dutch life sciences sector; Emerging technology; Opportunity matrix; Technology dynamics

Indexed keywords

BIOTECHNOLOGY; SEMICONDUCTOR QUANTUM DOTS;

DUTCH LIFE SCIENCES SECTOR; EMERGING TECHNOLOGY; NETHERLANDS; NETWORK VISUALIZATIONS; NEW APPROACHES; OPPORTUNITY MATRIX; RESEARCH QUESTIONS;

DYNAMICS;

EID: 60949086297     PISSN: 01664972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.technovation.2008.09.005     Document Type: Article

References (59)

1. Aharonson B.S., Baum J.A.C., and Plunket A. Inventive and uninventive clusters: the case of Canadian Biotechnology. Research Policy 37 (2008) 1108-1131
2. Ayres R.U. Toward a non-linear dynamics of technological progress. Journal of Economic Behavior and Organization 24 (1994) 35-69
3. Barnett W.P. The organizational ecology of a technological system. Administrative Science Quarterly 35 1 (1990) 31-60
4. Bartholomew S. National systems of biotechnology innovation: complex interdependencies in a global system. Journal of International Business Studies 28 2 (1997) 241-266
5. Baum J.A.C., and Rao H. Evolutionary dynamics of organizational populations and communities. In: Poole M.S., and Van de Ven A.H. (Eds). Handbook of Organizational Change and Innovation (2004), Oxford University Press, New York
6. Bigliardi B., Nosella A., and Verbano C. Business models in Italian biotechnology industry: a quantitative analysis. Technovation 25 (2005) 1299-1306
7. Bijker W.E., and Law J. Shaping Technology, Building Society: Studies in Sociotechnical Change (1992), MIT Press, Cambridge, MA
8. BioPartner, 2003. Growth against the tide: the Netherlands Life Sciences Sector report. Biopartner Network.
9. BioPartner, 2004. The Netherlands Life Sciences Sector report 2004: Moving forward. BioPartner Network.
10. BioPartner, 2005. The Netherlands Life Sciences Sector report 2005: new challenges ahead. BioPartner Network.
11. Borgatti S.P. NetDraw: Graph Visualization Software (2002), Analytic Technologies, Harvard
12. Breschi S., Lissoni F., and Malerba F. Knowledge-relatedness in firm technological diversification. Research Policy 32 (2003) 69-87
13. Brittain J.W., and Freeman J.H. Organizational proliferation and density dependent selection. In: Kimberly J.R., and Miles R.H. (Eds). The Organizational Life Cycle: Issues in the Creation, Transformation and Decline of Organizations (1980), Jossey-Bass Publishers, San Francisco, CA
14. Campbell N.A., Reece J.B., and Mitchell L.G. Biology (1999), Addison-Wesley, Menlo Park, CA
15. Cantner U., and Pyka A. Technological evolution-an analysis within the knowledge-based approach. Structural Change and Economic Dynamics 9 (1998) 85-107
16. Critical I, 2006. Biotechnology in Europe: 2006 comparative study. EuropaBio.
17. Crommelin D.J.A., and Sindelar R.D. Pharmaceutical Biotechnology: An Introduction for Pharmacists and Pharmaceutical Scientists (2002), Routledge, London
18. Deephouse. To be different or to be the same? It's a question (and theory) of strategic balance. Strategic Management Journal 20 2 (1999) 147-166
19. Duysters G.M., and Hagedoorn J. Technological convergence in the IT industry: the role of strategic technology alliances and technological competencies. International Journal of the Economics of Business 5 3 (1998) 355-368
20. Fuchs G., and Krauss G. Biotechnology in comparative perspective. In: Fuchs G. (Ed). Biotechnology in Comparative Perspective (2003), Routledge, London
21. Gambardella A., and Torrisi S. Does technological convergence imply convergence in markets? Evidence from the electronics industry. Research Policy 27 (1998) 445-463
22. Garud R., and Rappa M.A. A socio-cognitive model of technology evolution: the case of cochlear implants. Organization Science 5 3 (1994) 344-362
23. Gassmann O., Reepmeyer G., and Von Zedtwitz M. Leading Pharmaceutical Innovation. Trends and Drivers for Growth in the Pharmaceutical Industry (2004), Springer, Berlin
24. Gilsing V.A., and Duysters G.M. Understanding novelty creation in exploration networks: structural and relational embeddedness jointly considered. Technovation 28 (2008) 693-708
25. Hall L.A., and Bagchi-Sen S. An analysis of firm-level innovation strategies in the US biotechnology industry. Technovation 27 (2007) 4-14
26. Hopkins M.M., Martin P.A., Nightingale P., Kraft A., and Mahdi S. The myth of the biotech revolution: an assessment of technological, clinical and organisational change. Research Policy 36 (2007) 566-589
27. Ireland D.C., and Hine D. Harmonizing science and business agendas for growth in new biotechnology firms: case comparisons from five countries. Technovation 27 (2007) 676-692
28. Kash D.E., and Rycroft R. Emerging patterns of complex technological innovation. Technological Forecasting and Social Change 69 (2002) 581-606
29. Khilji E., Mroczkowski T., and Bernstein B. From invention to innovation: toward developing an integrated innovation model for biotech firms. Journal of Product Innovation Management 23 (2006) 528-540
30. Kim J.W., and Higgins M.C. Where do alliances come from? The effects of upper echelons on alliance formation. Research Policy 36 (2007) 499-514
31. Lemarié S., De Looze M.A., and Mangematin V. Strategies of European SMEs in biotechnology: the role of size technology and market. Scientometrics 47 3 (2000) 541-560
32. Levinthal D.A. The slow pace of rapid technological change: gradualism and punctuation in technological change. Industrial and Corporate Change 7 2 (1998) 217-247
33. Malerba F., and Orsenigo L. Schumpetarian patterns of innovation are technology-specific. Research Policy 25 (1996) 451-478
34. Malerba F., and Orsenigo L. Technological entry, exit and survival: an empirical analysis of patent data. Research Policy 28 (1999) 643-660
35. McKelvey M., Rickne A., and Laage-Hellman J. The Economic Dynamics of Modern Biotechnology (2004), Edward Elgar, Cheltenham
36. McKelvey M.D. Evolutionary Innovations: The Business of Biotechnology (1996), Oxford University Press, Oxford
37. Ministry of Economic Affairs, 1999. Action Plan Life Sciences 2000-2004. Ministry of Economic Affairs, The Hague.
38. Nelson R.R., and Winter S.G. An Evolutionary Theory of Economic Change (1982), The Belknap Press of Harvard University Press, Cambridge, MA
39. Nosella A., Petroni G., and Verbano C. Characteristics of the Italian biotechnology industry and new business models: the initial results of an empirical study. Technovation 25 (2005) 841-855
40. OECD, 2001. Biotechnology statistics in the OECD member countries: compendium of existing national statistics. STI Working Paper 2001/6, Directorate for Science, Technology and Industry, OECD.
41. Oosterwijk H. Sectoral Variations in National Systems of Innovation: The Case of Telecommunication and Modern Biotechnology. Social Sciences (2003), University of Utrecht, Utrecht, 504
42. Orsenigo L., Pammolli F., and Riccaboni M. Technological change and network dynamics: lessons for the pharmaceutical industry. Research Policy 30 3 (2001) 485-508
43. Pisano G.P. Science Business. The Promise, the Reality, and the Future of Biotech (2006), Harvard Business School Press, Boston, MA
44. Powell W.W., Koput K.W., White D.R., and Owen-Smith J. Network dynamics and field evolution: the growth of interorganisational collaboration in the life sciences. American Journal of Sociology 110 4 (2005) 1132-1205
45. Pyka, A., Saviotti, P., 2001. Innovation networks in the biotechnology-based sectors. Discussion papers, Institute for Economics, Universitaet Augsburg.
46. Quintana-Garcia C., and Benavides-Velasco C.A. Innovative competence, exploration and exploitation: the influence of technological diversification. Research Policy 37 (2008) 492-507
47. Rao H., and Singh J.V. Organizational speciation as new path creation: institution building activity in the early automobile and bio-tech industries. In: Garud R., and Karnoe P. (Eds). Path Dependence and Creation (2001), Lawrence Erlbaum, London 243-269
48. Rosenberg N. Inside the Black Box: Technology and Economics (1982), Cambridge University Press, Cambridge
49. Santos F.M. The coevolution of firms and their knowledge environment: insights from the pharmaceutical industry. Technological Forecasting and Social Change 70 (2003) 687-715
50. Saviotti P., De Looze M.A., and Maupertuis M.A. Knowledge dynamics, firm strategy, mergers and acquisitions in the biotechnology-based sectors. Economics of Innovation and New Technology 14 1 (2005) 103-124
51. Simon H.A. Models of Man: Social and Rational (1957), Wiley, New York
52. Terziovski M., and Morgan J.P. Management practices and strategies to accelerate the innovation cycle in the biotechnology industry. Technovation 26 (2006) 545-552
53. Van de Ven A.H., Polley D.E., Garud R., and Venkataraman S. The Innovation Journey (1999), Oxford University Press, New York/Oxford
54. Van der Valk, T., 2007. Technology dynamics, network dynamics and partnering: the case of Dutch dedicated life sciences firms. Ph.D. Thesis, Netherlands Geographical Studies.
55. Walsh G. Biopharmaceuticals: recent approvals and likely directions. Trends in Biotechnology 23 11 (2005) 553-558
56. Willemstein L., Van der Valk T., and Meeus M.T.H. Dynamics in business models: an empirical analysis of medical biotechnology firms in the Netherlands. Technovation 27 (2007) 221-232
57. Wonnacott T.H., and Wonnacott R.J. Introductory Statistics (1990), Wiley, New York
58. Xia T., and Roper S. From capability to connectivity-absorptive capacity and exploratory alliances in biopharmaceutical firms: a US-Europe comparison. Technovation 28 (2008) 776-785
59. Zhang J., Baden-Fuller C., and Mangematin V. Technological knowledge base, R&D organization structure and alliance formation: evidence from the biopharmaceutical industry. Research Policy 36 (2007) 515-528